Document is current
Any future updates will be listed below
-
Authors
Beck, Tara
Isaac, Jaya
Deutmeyer, Miranda
Starr, Michelle C.
Slagle, Cara
Askenazi, David J.
Goldstein, Stuart L.
Selewski, David T.
- License Information
-
More Information
Article History
Received: 1 August 2025
Accepted: 4 August 2025
First Online: 15 September 2025
Competing interests
: Tara Beck, Jaya Isaac, Miranda Deutmeyer, and Michelle C Starr have nothing to disclose. The following authors have disclosures: David T Selewski is a consultant for Bioporto Diagnostics. Cara Slagle is a consultant for Bioporto Diagnostics. Stuart L Goldstein: MediBeacon (Consultant, Director of Clinical Development, Shareholder), Vantive Healthcare (Grant Support/Expert Panel/Consultant), SeaStar (Grant Support/Expert Panel/Consultant), BioPorto Diagnostics (Grant Support/Consultant), Medtronic (Mozarc, Grant Support/Consultant), NuWellis (Grant Support/Consultant), Fresenius (Consultant), Calcimedica (Consultant), Novartis (Consultant), Otsuka (Consultant). David J Askenazi has consulted with Nuwellis, and Seastar. He has financial interests in patent/innovations in the area of urine collection and fluid balance devices. He is the Founder and Chief Scientific Officer for Zorro-Flow Inc.
